Bayer and Leica Biosystems unite to fight cancer
Bayer has entered into an agreement with Leica Biosystems to collaborate on the development of companion diagnostic tests based on…
Pharmaceuticals, Biotechnology and Life Sciences
Bayer has entered into an agreement with Leica Biosystems to collaborate on the development of companion diagnostic tests based on…
Bayer and Boehringer Ingelheim Vetmedica, Inc. (BIVI) have made a deal for Bayer to buy BIVI’s Cydectin bovine and ovine…
Bayer on Monday announced the submission of applications to extend the marketing authorization for its oral multi-kinase inhibitor
The Bayer Group remained on a path of growth in the third quarter of 2016 and took a major step forward…
Bayer has announced that the acquisition facilities of USD 56.9 billion that Bayer had agreed with five underwriter banks (BofA Merrill Lynch, Credit Suisse, Goldman Sachs, HSBC and JP Morgan) prior to announcement of the Monsanto acquisition has now been successfully syndicated within the group of Bayer’s core relationship banks.
The non-interventional XALIA study in patients with deep vein thrombosis (DVT) and a study in patients with cancer-associated thrombosis (CAT) – both showing low rates of major bleeding and recurrent venous thromboembolism (VTE) with Xarelto (rivaroxaban). Results from the two studies were presented at the 2015 ASH Annual Meeting, and XALIA findings were also simultaneously published in the Lancet Haematology.
Bayer has submitted an application for marketing authorization in both the European Union and in the United States for LCS-16, a new low-dose levonorgestrel-releasing intrauterine system
Bayer has announced that from September 30th to October first, Bayer CropScience is hosting over 175 industry professionals from over 15 different countries at its Horticulture Symposium in Puerto Vallarta, Mexico.
Bayer CropScience inaugurated its new European Oilseed Processing Center in Monheim at a ceremony attended by industry representatives, authorities, agricultural stakeholders and customers.
The European Committee for Medicinal Products for Human Use (CHMP) has recommended Bayer’s aflibercept solution for injection into the eye…